|Hepatitis C in Egypt|
In Egypt, the epidemiological and social situation differs from that of Western countries. HCV prevalence is very high (estimated among adults at 10 and 20% in urban and rural areas, respectively). The origin of the epidemic has been attributed to mass campaigns of parenteral anti-schistosomiasis treatment in rural areas in the 1960s–70s.
Since then, the virus has continued to spread, mainly through intravenous injections and other medical procedures. An important difference about the epidemic in Egypt is that >95% of infections are HCV genotype 4 (HCVg4). Currently, >8 million people infected with HCVg4 and the incidence of new infections remains the highest, worldwide.
|SPHINX-HepaCute joint workshop EASL conference, London April 9th 2014|